Business Description
Regentis Biomaterials is an Israeli medical company, founded in 2004 and headquartered in Herzliya, that focuses on healing damaged tissue in the human body. Its main product line centers on a gel-based material designed to repair cartilage and other injured tissues, with one treatment specifically targeting knee cartilage damage currently being evaluated in a Phase II clinical trial. The company sells its products primarily in the United States.
